Skip to main content
SpringerLink
Log in
Book cover

Pediatric Endocrinology pp 291–307Cite as

Autoimmune Thyroid Disease

  • Chapter

  • 254 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Autoimmune thyroid disease is the most common autoimmune condition, affecting approximately 2% of the female population and 0.2% of the male population (1). Its overall prevalence peaks in adulthood, but it is also the most common etiology of acquired thyroid dysfunction in pediatrics (2,3). This chapter presents a summary of autoimmune thyroid disease, discussing first chronic autoimmune thyroiditis and then Graves’ disease, with an emphasis on their clinical management. Optimal quantities of thyroid hormone are critical to neurodevelopment and growth. By maintaining an appropriate index of suspicion, the clinician can often recognize thyroid dysfunction in its early stages.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001; 30 (2): 315–337.

    Article  PubMed  CAS  Google Scholar 

  2. Hunter I, Greene SA, MacDonald TM, et al. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child 2000; 83 (3): 207–210.

    Article  PubMed  CAS  Google Scholar 

  3. Segni M, Leonardi E, Mazzoncini B, et al. Special features of Graves’ disease in early childhood. Thyroid 1999; 9 (9): 871–817.

    Article  PubMed  CAS  Google Scholar 

  4. Lafranchi S. Thyroiditis and acquired hypothyroidism. Pediatr Ann 1992;21(1): 29, 32–39.

    Google Scholar 

  5. Foley TP Jr, Abbassi V, Copeland KC, et al. Brief report: hypothyroidism caused by chronic autoimmune thyroiditis in very young infants. N Engl J Med 1994; 330 (7): 466–468.

    Article  PubMed  Google Scholar 

  6. Ostergaard GZ, Jacobsen BB. Atrophic, autoimmune thyroiditis in infancy. A case report. Horm Res 1989; 31 (4): 190–192.

    Article  PubMed  CAS  Google Scholar 

  7. Davies TF, Amino N. A new classification for human autoimmune thyroid disease. Thyroid 1993; 3 (4): 331–333.

    Article  PubMed  CAS  Google Scholar 

  8. Larsen PR, Davies TF, Hay ID. The Thhyroid Gland. In: Williams Textbook of Endocrinology, 9th ed. Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. W.B. Saunders Company, Philadelphia, 1998, pp. 389–515.

    Google Scholar 

  9. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335 (2): 99–107.

    Article  PubMed  CAS  Google Scholar 

  10. Matsuura N, Konishi J, Yuri K, et al. Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies. Eur J Pediatr 1990; 149 (8): 529–533.

    Article  PubMed  CAS  Google Scholar 

  11. Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992; 326 (8): 513–518.

    Article  PubMed  CAS  Google Scholar 

  12. Foley TP. Disorders of the Thyroid in Childern. In: Pediattric Endocrinology, Sperling MA, ed. W.B. Saunders Company, Philadelphia, 1996, pp. 171–194.

    Google Scholar 

  13. Chiesa A, Gruniero de Papendieck L, Keselman A, et al. Final height in long-term primary hypothyroid children. J Pediatr Endocrinol Metab, 1998; 11 (1): 51–58.

    Article  PubMed  CAS  Google Scholar 

  14. Boersma B, Otten BJ, Stoelinga GB, et al. Catch-up growth after prolonged hypothyroidism. Eur J Pediatr 1996; 155 (5): 362–367.

    Article  PubMed  CAS  Google Scholar 

  15. Castro-Magana M, Angulo M, Canas A, et al. Hypothalamic-pituitary gonadal axis in boys with primary hypothyroidism and macroorchidism. J Pediatr 1988; 112 (3): 397–402.

    Article  PubMed  CAS  Google Scholar 

  16. Jannini EA, Ulisse S, D’Armiento M. Macroorchidism in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80 (8): 2543–2544.

    PubMed  CAS  Google Scholar 

  17. Anasti, JN, Flack MR, Froehlich J, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80 (1): 276–279.

    Article  PubMed  CAS  Google Scholar 

  18. Lum SM, Nicoloff JT, Spencer CA, et al. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest 1984; 73 (2): 570–575.

    Article  PubMed  CAS  Google Scholar 

  19. Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23 (1): 38–89.

    Article  PubMed  CAS  Google Scholar 

  20. Nordyke RA, Gilbert FI, Jr., Miyamoto LA, et al. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto’s thyroiditis. Arch Intern Med 1993; 153 (7): 862–865.

    Article  PubMed  CAS  Google Scholar 

  21. Foley TP Jr. Mediators of thyroid diseases in children. J Pediatr, 1998; 132 (4): 569–570.

    Article  PubMed  Google Scholar 

  22. Hancock SL, McDougall IR, Constine LS, Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys, 1995. 31 (5): p. 1165–70.

    Article  PubMed  CAS  Google Scholar 

  23. Huang SA, Fish DA, Dorfman DM, Salvatore D, Kozakewich HP, Mandel SJ, Larsen PR. A 21 year Old Woman with Consumptive Hypothyroidism due to a Vascular Tumor Expressing Type 3 Iodothyronine Deiodinase. Journal of Clinical Endocrinology Metabolism, 2002; 87 (10): 4457–4461.

    Article  PubMed  CAS  Google Scholar 

  24. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. New England Journal of Medicine 2000; 343 (3): 185–189.

    Article  PubMed  CAS  Google Scholar 

  25. Ayling RM, Davenport M, Hadzic N, et al. Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. Journal of Pediatrics 2001; 138 (6): 932–935.

    Article  PubMed  CAS  Google Scholar 

  26. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993; 119 (6): 492–502.

    PubMed  CAS  Google Scholar 

  27. Van Dop C, Conte FA, Kock TK, et al. Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med 1983; 308 (18): 1076–1080.

    Article  PubMed  Google Scholar 

  28. Slyper AH, Swenerton P. Experience with low-dose replacement therapy in the initial management of severe pediatric acquired primary hypothyroidism. J Pediatr Endocrinol Metab 1998; 11 (4): 543–547.

    Article  PubMed  CAS  Google Scholar 

  29. Sklar CA, Qazi R, David R. Juvenile autoimmune thyroiditis. Hormonal status at presentation and after long-term follow-up. Am J Dis Child 1986; 140 (9): 877–880.

    PubMed  CAS  Google Scholar 

  30. Maenpaa J, Raatikka M, Rasanen J, et al. Natural course of juvenile autoimmune thyroiditis. J Pediatr 1985; 107 (6): 898–904.

    Article  PubMed  CAS  Google Scholar 

  31. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341 (8): 549–555.

    Article  PubMed  CAS  Google Scholar 

  32. Weetman AP. Graves’ disease. N Engl J Med 2000; 343 (17): 1236–1248.

    Article  PubMed  CAS  Google Scholar 

  33. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998 27 (1): 109–126.

    Article  PubMed  CAS  Google Scholar 

  34. Lavard L, Ranlov I, Perrild H, et al. Incidence of juvenile thyrotoxicosis in Denmark, 1982–1988. A nationwide study. Eur J Endocrinol 1994; 130 (6): 565–568.

    Article  PubMed  CAS  Google Scholar 

  35. Gruters A. Ocular manifestations in children and adolescents with thyrotoxicosis. Exp Clin Endocrinol Diabetes 1999;107:172-S 174.

    Google Scholar 

  36. Buckler JM, Willgerodt H, Keller E. Growth in thyrotoxicosis. Arch Dis Child 1986; 61 (5): 464–471.

    Article  PubMed  CAS  Google Scholar 

  37. Wong GW, Lai J, Cheng PS. Growth in childhood thyrotoxicosis. Eur J Pediatr 1999; 158 (10): 776–779.

    Article  PubMed  CAS  Google Scholar 

  38. Deroot LJ, Larsen PR, Henneman G. Acute and Subacute Thyroiditis. In: The Thyroif and Its Diseases, 6th ed. DeGroot LJ, Larsen PR, Henneman G. eds. Churchill Livingstone, New York, pp. 697–709.

    Google Scholar 

  39. Marqusee, E., S.T. Haden, and R.D. Utiger, Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27 (1): 37–49.

    Article  PubMed  CAS  Google Scholar 

  40. Koutras DA. Subclinical hyperthyroidism. Thyroid 1999; 9 (3): 311–315.

    Article  PubMed  CAS  Google Scholar 

  41. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331 (19); 1249–1252.

    Article  PubMed  CAS  Google Scholar 

  42. Utiger RD. Subclinical hyperthyroidismjust a low serum thyrotropin concentration, or something more? N Engl J Med 1994; 331 (19): 1302–1303.

    Article  PubMed  CAS  Google Scholar 

  43. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994, 330 (24): 1731–1738.

    Article  PubMed  CAS  Google Scholar 

  44. Klein I, Becker DV, Levey GS. Treatment of hyperthyroid disease. Ann Intern Med 1994, 121 (4): 281–288.

    PubMed  CAS  Google Scholar 

  45. Hashizume K, Ichikawa K, Sakurai A, et al. Administration of thyroxine in treated Graves’ disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 1991; 324 (14): 947–953.

    Article  PubMed  CAS  Google Scholar 

  46. McIver B, Rae P, Beckett G, et al. Lack of effect of thyroxine in patients with Graves’ hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 1996; 334 (4): 220–224.

    Article  PubMed  CAS  Google Scholar 

  47. Lucas A, Salinas I, Rius F, et al. Medical therapy of Graves’ disease: does thyroxine prevent recurrence of hyperthyroidism? J Clin Endocrinol Metab 1997; 82 (8): 2410–2413.

    Article  PubMed  CAS  Google Scholar 

  48. Rivkees SA, Sklar C, Freemark M. Clinical review 99: The management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83 (11): 3767–3776.

    Article  PubMed  CAS  Google Scholar 

  49. Lazar L, Kalter-Leibovici O, Pertzelan A, et al. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 2000; 85 (10): 3678–3682.

    Article  PubMed  CAS  Google Scholar 

  50. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983; 98 (1): 26–29.

    PubMed  CAS  Google Scholar 

  51. LaFranchi, Hanna CE. Graves Disease in the Neonatal Period and Childhood. In: Werner Ingbar’s The Thyroid. A Fundamental and Clinical Text, Braverman LE, Utiger RD, eds. Lipppincott Williams Wilkins, Philadelphia, 2000, pp. 989–997.

    Google Scholar 

  52. Shulman DI, Muhar I, Jorgensen EV, et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997; 7 (5): 755–760.

    Article  PubMed  CAS  Google Scholar 

  53. Raza J, Hindmarsh PC, Brook CG. Thyrotoxicosis in children: thirty years’ experience. Acta Paediatr 1999; 88 (9): 937–941.

    Article  PubMed  CAS  Google Scholar 

  54. Ward L, Huot C, Lambert R, et al. Outcome of pediatric Graves’ disease after treatment with antithyroid medication and radioiodine. Clin Invest Med 1999; 22 (4): 132–139.

    PubMed  CAS  Google Scholar 

  55. Moll GW Jr, Patel BR. Pediatric Graves’ disease: therapeutic options and experience with radioiodine at the University of Mississippi Medical Center. South Med J 1997; 90 (10): 1017–1022.

    Article  PubMed  Google Scholar 

  56. Clark JD, Gelfand MJ, Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995; 36 (3): 442–445.

    PubMed  CAS  Google Scholar 

  57. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 1975; 292 (4): 167–171.

    Article  PubMed  CAS  Google Scholar 

  58. Foley TP Jr, Charron M. Radioiodine treatment of juvenile Graves disease. Exp Clin Endocrinol Diabetes 1997; 105: 61–65.

    Article  PubMed  CAS  Google Scholar 

  59. Cheetham TD, Wraight P, Hughes IA, et al. Radioiodine treatment of Graves’ disease in young people. Horm Res 1998; 49 (6): 258–262.

    Article  PubMed  CAS  Google Scholar 

  60. Refetoff S, Harrison J, Karanfilski BT, et al. Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 1975; 292 (4): 171–175.

    Article  PubMed  CAS  Google Scholar 

  61. Baverstock K, Egloff B, Pinchera A, et al. Thyroid cancer after Chernobyl. Nature 1992; 359 (6390): 21–22.

    Article  PubMed  CAS  Google Scholar 

  62. Nikiforov Y, Gnepp DR, J.A. Fagin, Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab, 1996, 81 (1): p. 9–14.

    Article  PubMed  CAS  Google Scholar 

  63. Alexander EK, Larsen PR. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves’ disease. J Clin Endocrinol Metab 2002; 87 (3): 1073–1077.

    Article  PubMed  CAS  Google Scholar 

  64. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med 1998; 338 (2): 73–78.

    Article  PubMed  CAS  Google Scholar 

  65. Soreide JA, van Heerden JA, Lo CY, et al. Surgical treatment of Graves’ disease in patients younger than 18 years. World J Surg 1996; 20 (7): 794–799.

    Article  PubMed  CAS  Google Scholar 

  66. Sosa JA, Bowman M, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228 (3): 320–330.

    Article  PubMed  CAS  Google Scholar 

  67. Waldhausen JH. Controversies related to the medical and surgical management of hyperthyroidism in children. Semin Pediatr Surg 1997; 6 (3): 121–127.

    PubMed  CAS  Google Scholar 

  68. Laurberg P, Nygaard B, Gilnoer D, et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998; 139 (6): 584–586.

    Article  PubMed  CAS  Google Scholar 

  69. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992; 2 (2): 155–159.

    Article  PubMed  CAS  Google Scholar 

  70. Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves’ disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983; 57 (5): 1036–1040.

    Article  PubMed  CAS  Google Scholar 

  71. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999; 9 (7): 727–733.

    Article  PubMed  CAS  Google Scholar 

  72. Mandel SH, Hanna CE, LaFranchi SH. Diminished thyroid-stimulating hormone secretion associated with neonatal thyrotoxicosis. J Pediatr 1986; 109 (4): 662–665.

    Article  PubMed  CAS  Google Scholar 

  73. Hashimoto H, Maruyama H, Koshida R, et al. Central hypothyroidism resulting from pituitary suppression and peripheral thyrotoxicosis in a premature infant born to a mother with Graves disease. J Pediatr 1995; 127 (5): 809–811.

    Article  PubMed  CAS  Google Scholar 

  74. Mandel S, Hanna C, LaFranchi S. Thyroid function of infants born to mothers with Graves disease. J Pediatr 1990; 117: 169–170.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Stephen A. Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Reed Larsen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Pediatric Endocrinology, University of Chicago Medical Center, Chicago, IL, USA

    Sally Radovick MD

  2. Division of Endocrinology, Children’s Hospital of Buffalo, Buffalo, NY, USA

    Margaret H. MacGillivray MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Huang, S.A., Larsen, P.R. (2003). Autoimmune Thyroid Disease. In: Radovick, S., MacGillivray, M.H. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-336-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-336-1_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-268-1

  • Online ISBN: 978-1-59259-336-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation